Companion Cancer Diagnostics Market, Global Outlook and Forecast 2022-2028

January 2022 | 69 pages | ID: C94EE25B63F6EN
Market Monitor Global

Abstracts

A Companion Cancer Diagnostics is a diagnostic test used as a companion to a therapeutic drug to determine its applicability to a specific person.

Companion Cancer Diagnostics are co-developed with drugs to aid in selecting or excluding patient groups for treatment with that particular drug on the basis of their biological characteristics that determine responders and non-responders to the therapy.

This report contains market size and forecasts of Companion Cancer Diagnostics in Global, including the following market information:

Global Companion Cancer Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Companion Cancer Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Breast Cancer Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Companion Cancer Diagnostics include F. Hoffmann-La Roche, Agilent Technologies, QIAGEN, Abbott Laboratories, Almac Group, Danaher Corporation, bioM?rieuxSA and Myriad Genetics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Companion Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Companion Cancer Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Companion Cancer Diagnostics Market Segment Percentages, by Type, 2021 (%)

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Melanoma
• Gastric Cancer

Global Companion Cancer Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Companion Cancer Diagnostics Market Segment Percentages, by Application, 2021 (%)

• Pharmaceutical & Biopharmaceutical Companies
• Reference Laboratories
• CROs
• Others

Global Companion Cancer Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Companion Cancer Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Companion Cancer Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Companion Cancer Diagnostics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• F. Hoffmann-La Roche
• Agilent Technologies
• QIAGEN
• Abbott Laboratories
• Almac Group
• Danaher Corporation
• bioM?rieuxSA
• Myriad Genetics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Companion Cancer Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Companion Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COMPANION CANCER DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global Companion Cancer Diagnostics Market Size: 2021 VS 2028
2.2 Global Companion Cancer Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Companion Cancer Diagnostics Players in Global Market
3.2 Top Global Companion Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Companion Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Companion Cancer Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Companion Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Companion Cancer Diagnostics Players in Global Market
  3.6.1 List of Global Tier 1 Companion Cancer Diagnostics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Companion Cancer Diagnostics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Companion Cancer Diagnostics Market Size Markets, 2021 & 2028
  4.1.2 Breast Cancer
  4.1.3 Lung Cancer
  4.1.4 Colorectal Cancer
  4.1.5 Melanoma
  4.1.6 Gastric Cancer
4.2 By Type - Global Companion Cancer Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global Companion Cancer Diagnostics Revenue, 2017-2022
  4.2.2 By Type - Global Companion Cancer Diagnostics Revenue, 2023-2028
  4.2.3 By Type - Global Companion Cancer Diagnostics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Companion Cancer Diagnostics Market Size, 2021 & 2028
  5.1.2 Pharmaceutical & Biopharmaceutical Companies
  5.1.3 Reference Laboratories
  5.1.4 CROs
  5.1.5 Others
5.2 By Application - Global Companion Cancer Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global Companion Cancer Diagnostics Revenue, 2017-2022
  5.2.2 By Application - Global Companion Cancer Diagnostics Revenue, 2023-2028
  5.2.3 By Application - Global Companion Cancer Diagnostics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Companion Cancer Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Companion Cancer Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global Companion Cancer Diagnostics Revenue, 2017-2022
  6.2.2 By Region - Global Companion Cancer Diagnostics Revenue, 2023-2028
  6.2.3 By Region - Global Companion Cancer Diagnostics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Companion Cancer Diagnostics Revenue, 2017-2028
  6.3.2 US Companion Cancer Diagnostics Market Size, 2017-2028
  6.3.3 Canada Companion Cancer Diagnostics Market Size, 2017-2028
  6.3.4 Mexico Companion Cancer Diagnostics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Companion Cancer Diagnostics Revenue, 2017-2028
  6.4.2 Germany Companion Cancer Diagnostics Market Size, 2017-2028
  6.4.3 France Companion Cancer Diagnostics Market Size, 2017-2028
  6.4.4 U.K. Companion Cancer Diagnostics Market Size, 2017-2028
  6.4.5 Italy Companion Cancer Diagnostics Market Size, 2017-2028
  6.4.6 Russia Companion Cancer Diagnostics Market Size, 2017-2028
  6.4.7 Nordic Countries Companion Cancer Diagnostics Market Size, 2017-2028
  6.4.8 Benelux Companion Cancer Diagnostics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Companion Cancer Diagnostics Revenue, 2017-2028
  6.5.2 China Companion Cancer Diagnostics Market Size, 2017-2028
  6.5.3 Japan Companion Cancer Diagnostics Market Size, 2017-2028
  6.5.4 South Korea Companion Cancer Diagnostics Market Size, 2017-2028
  6.5.5 Southeast Asia Companion Cancer Diagnostics Market Size, 2017-2028
  6.5.6 India Companion Cancer Diagnostics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Companion Cancer Diagnostics Revenue, 2017-2028
  6.6.2 Brazil Companion Cancer Diagnostics Market Size, 2017-2028
  6.6.3 Argentina Companion Cancer Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Companion Cancer Diagnostics Revenue, 2017-2028
  6.7.2 Turkey Companion Cancer Diagnostics Market Size, 2017-2028
  6.7.3 Israel Companion Cancer Diagnostics Market Size, 2017-2028
  6.7.4 Saudi Arabia Companion Cancer Diagnostics Market Size, 2017-2028
  6.7.5 UAE Companion Cancer Diagnostics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 F. Hoffmann-La Roche
  7.1.1 F. Hoffmann-La Roche Corporate Summary
  7.1.2 F. Hoffmann-La Roche Business Overview
  7.1.3 F. Hoffmann-La Roche Companion Cancer Diagnostics Major Product Offerings
  7.1.4 F. Hoffmann-La Roche Companion Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.1.5 F. Hoffmann-La Roche Key News
7.2 Agilent Technologies
  7.2.1 Agilent Technologies Corporate Summary
  7.2.2 Agilent Technologies Business Overview
  7.2.3 Agilent Technologies Companion Cancer Diagnostics Major Product Offerings
  7.2.4 Agilent Technologies Companion Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.2.5 Agilent Technologies Key News
7.3 QIAGEN
  7.3.1 QIAGEN Corporate Summary
  7.3.2 QIAGEN Business Overview
  7.3.3 QIAGEN Companion Cancer Diagnostics Major Product Offerings
  7.3.4 QIAGEN Companion Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.3.5 QIAGEN Key News
7.4 Abbott Laboratories
  7.4.1 Abbott Laboratories Corporate Summary
  7.4.2 Abbott Laboratories Business Overview
  7.4.3 Abbott Laboratories Companion Cancer Diagnostics Major Product Offerings
  7.4.4 Abbott Laboratories Companion Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.4.5 Abbott Laboratories Key News
7.5 Almac Group
  7.5.1 Almac Group Corporate Summary
  7.5.2 Almac Group Business Overview
  7.5.3 Almac Group Companion Cancer Diagnostics Major Product Offerings
  7.5.4 Almac Group Companion Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.5.5 Almac Group Key News
7.6 Danaher Corporation
  7.6.1 Danaher Corporation Corporate Summary
  7.6.2 Danaher Corporation Business Overview
  7.6.3 Danaher Corporation Companion Cancer Diagnostics Major Product Offerings
  7.6.4 Danaher Corporation Companion Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.6.5 Danaher Corporation Key News
7.7 bioM?rieuxSA
  7.7.1 bioM?rieuxSA Corporate Summary
  7.7.2 bioM?rieuxSA Business Overview
  7.7.3 bioM?rieuxSA Companion Cancer Diagnostics Major Product Offerings
  7.7.4 bioM?rieuxSA Companion Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.7.5 bioM?rieuxSA Key News
7.8 Myriad Genetics
  7.8.1 Myriad Genetics Corporate Summary
  7.8.2 Myriad Genetics Business Overview
  7.8.3 Myriad Genetics Companion Cancer Diagnostics Major Product Offerings
  7.8.4 Myriad Genetics Companion Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.8.5 Myriad Genetics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Companion Cancer Diagnostics Market Opportunities & Trends in Global Market
Table 2. Companion Cancer Diagnostics Market Drivers in Global Market
Table 3. Companion Cancer Diagnostics Market Restraints in Global Market
Table 4. Key Players of Companion Cancer Diagnostics in Global Market
Table 5. Top Companion Cancer Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Companion Cancer Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Companion Cancer Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Companion Cancer Diagnostics Product Type
Table 9. List of Global Tier 1 Companion Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Companion Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Companion Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Companion Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Companion Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Companion Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Companion Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Companion Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Companion Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Companion Cancer Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Companion Cancer Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Companion Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Companion Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Companion Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Companion Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Companion Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. F. Hoffmann-La Roche Corporate Summary
Table 31. F. Hoffmann-La Roche Companion Cancer Diagnostics Product Offerings
Table 32. F. Hoffmann-La Roche Companion Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Agilent Technologies Corporate Summary
Table 34. Agilent Technologies Companion Cancer Diagnostics Product Offerings
Table 35. Agilent Technologies Companion Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. QIAGEN Corporate Summary
Table 37. QIAGEN Companion Cancer Diagnostics Product Offerings
Table 38. QIAGEN Companion Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Abbott Laboratories Corporate Summary
Table 40. Abbott Laboratories Companion Cancer Diagnostics Product Offerings
Table 41. Abbott Laboratories Companion Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Almac Group Corporate Summary
Table 43. Almac Group Companion Cancer Diagnostics Product Offerings
Table 44. Almac Group Companion Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. Danaher Corporation Corporate Summary
Table 46. Danaher Corporation Companion Cancer Diagnostics Product Offerings
Table 47. Danaher Corporation Companion Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. bioMerieuxSA Corporate Summary
Table 49. bioMerieuxSA Companion Cancer Diagnostics Product Offerings
Table 50. bioMerieuxSA Companion Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. Myriad Genetics Corporate Summary
Table 52. Myriad Genetics Companion Cancer Diagnostics Product Offerings
Table 53. Myriad Genetics Companion Cancer Diagnostics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Companion Cancer Diagnostics Segment by Type in 2021
Figure 2. Companion Cancer Diagnostics Segment by Application in 2021
Figure 3. Global Companion Cancer Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Companion Cancer Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Companion Cancer Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Companion Cancer Diagnostics Revenue in 2021
Figure 8. By Type - Global Companion Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Companion Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Companion Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Companion Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Companion Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Companion Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Companion Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Companion Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Companion Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. F. Hoffmann-La Roche Companion Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Agilent Technologies Companion Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. QIAGEN Companion Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Abbott Laboratories Companion Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Almac Group Companion Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Danaher Corporation Companion Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. bioMerieuxSA Companion Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Myriad Genetics Companion Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)